Lifespan Vision Ventures Invests In Bolden Therapeutics

Jan 09, 2024•almost 2 years ago

ProvidenceBiotechnology

Investors

Life Span Vision Ventures

Description

LifeSpan Vision Ventures, an investment firm that specializes in funding longevity biotech breakthroughs, today announced an investment in Bolden Therapeutics, Inc. This biotechnology company is developing first-in-class therapeutics to promote neurogenesis for the potential treatment of central nervous system diseases.

Company Information

Company

Bolden Therapeutics

Location

Providence, Rhode Island, United States

About

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke. The company’s scientific founders have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons (neurogenesis) in the adult brain. In a proprietary mouse model Bolden has established a proof-of-concept of this approach to increase neurogenesis and enhance hippocampal-dependent memory. The company is actively developing antisense oligonucleotide and monoclonal antibody therapeutics to modulate this pathway.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns